Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020
Dispatch

Mycobacterial Testing Trends, United States, 2009–20151

Samantha G. Dean, Emily E. Ricotta, Jonathan Fintzi, Yi Ling Lai2, Sameer S. Kadri, Kenneth N. Olivier, Adrian Zelazny, and D. Rebecca PrevotsComments to Author 
Author affiliations: National Institutes of Health, Bethesda, Maryland, USA

Main Article

Figure 2

Annual percentage change in identified pathogenic nontuberculous mycobacteria (NTM) in 31 facilities, United States, 2009–2015. Red indicates increasing trends; blue indicates decreasing trends. Error bars indicate 95% CI. COPD, chronic obstructive pulmonary disease.

Figure 2. Annual percentage change in identified pathogenic nontuberculous mycobacteria (NTM) in 31 facilities, United States, 2009–2015. Red indicates increasing trends; blue indicates decreasing trends. Error bars indicate 95% CI. COPD, chronic obstructive pulmonary disease.

Main Article

1Preliminary results from this study were presented at the IDWeek Conference; October 2–6, 2019; Washington, DC, USA.

2Current affiliation: Kaiser Permanente, Oakland, California, USA.

Page created: June 15, 2020
Page updated: August 19, 2020
Page reviewed: August 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external